Updated: Reddy's Follows Endo On US Kuvan Launch

Sapropterin Market Worth Roughly $500m

 
• By Dean Rudge
Red_Rocket
Both Endo and Reddy's have now launched generic Kuvan tablets following patent-litigation settlements • Source: Shutterstock

More from Products

More from Generics Bulletin